D
DND PharmaTech Inc
KOSDAQ:347850
DND PharmaTech Inc
KOSDAQ:347850
Price:
81 600
KRW
-2.28%
Market Cap:
₩3.6T
DND PharmaTech Inc
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
DND PharmaTech Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Other
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other
₩628.1B
|
CAGR 3-Years
88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other
-₩60.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other
-₩23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other
-₩55.4m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
DND PharmaTech Inc
Glance View
DND PharmaTech Inc is a KR-based company operating in Biotechnology industry. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2024-05-02. DND Pharmatech Inc is a Korea-based clinical-stage biotech company mainly engaged in the research and development in medicines. The firm's product pipeline mainly focuses on indications including metabolic disease, neurodegenerative and fibrotic diseases. In addition, the Company is engaged in the research and development of therapeutic medicines used for diabetes, obesity and nonalcoholic steatohepatitis as well as others.
Intrinsic Value
3 699.67
KRW
Overvaluation 95%
D
See Also
What is DND PharmaTech Inc's Other?
Other
0
KRW
0
KRW
Based on the financial report for Dec 31, 2024, DND PharmaTech Inc's Other amounts to 0 KRW.
